Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 41017
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
41017
Date of registration
18.08.1977
Company name
Sanofi-Aventis (Suisse) SA
Revision date
28.04.2006
Valid until
29.11.2019
Indication
Date of market entry
Index Therapeuticus (BSV)
07.06.20.
Revocation Date
18.08.2015
Index Therapeuticus (Swissmedic)
07.06.20.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
Semi-Daonil
comprimés
Tablets (Glibenclamide 2.5 mg)
A10BB01
CI
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
